NEXGEL, Inc (NXGL) - Forward Price-to-Revenue Multiple

NEXGEL, Inc. (NXGL) develops advanced hydrogel patches for prolonged drug delivery. The estimated forward P/S exhibits a downward trend, where the 0.20 mark characterizes this parameter. Polymer import risks and logistical disruptions are offset by stable demand in dermatology, which sustains high business margins amid a general macroeconomic upturn for specialized medical devices.

NXGL nexgel.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

NEXGEL Inc - analytical breakdowns and key metrics (NXGL)

- market price and analyst price targets:

Price Chart NEXGEL|NXGL - Fair Value Consensus

- market capitalization indicators:

Market Valuation NEXGEL Inc|NXGL - Enterprise Value

- business book valuation details:

Net Assets per Single Share NEXGEL|NXGL - Company Net Assets|Market Capitalization to Book Value Ratio nexgel.com|NXGL - Company Assets

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

NXGL - Company Net Income|Future Profit NEXGEL, Inc.|NXGL - Price to Earnings Multiple|Forward P/E Multiple NEXGEL, Inc|NXGL - Price to Net Income Growth Ratio|EV/EBITDA Multiple NEXGEL Inc|NXGL - Profit before interest, taxes and amortization|Earnings per share for the last twelve months NEXGEL|NXGL - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months nexgel.com|NXGL - Earnings per share increase in current year|Earnings growth forecast for next year NEXGEL, Inc.

- sales and revenue data:

NXGL - Company Gross Revenue|Company Projected Revenue NEXGEL|NXGL - Market Cap to Revenue Ratio|Forward P/S Multiple NEXGEL Inc

General company analysis:NXGL (NEXGEL)

Assessing the investment attractiveness of NEXGEL, Inc. (NXGL) requires analyzing the ratio of market capitalization to projected revenue to identify potential asset overvaluation. The forward P/S ratio demonstrates how many years of revenue an investor is paying per share today, which is critical as the company scales B2B contracts for hydrogel product manufacturing and develops its own e-commerce sales channels.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (icumed.com)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue STAA|NAGE (ChromaDex Corporation) - Forward P/S Multiple|Market Cap to Future Revenue Ratio zimvie.com ZIMV|Forward Price-to-Revenue Multiple ANGO (AngioDynamics)|Cerus Corp. - Market Cap to Projected Revenue|Forward P/S Multiple TKNO (Alpha Teknova Inc)|Projected Price to Revenue Monogram Orthopedics Inc.|Sharps Tech - Forward P/S Multiple|Market Cap to Future Revenue Ratio InfuSystem Holdings|Utah Medical Products, Inc. (UTMD) - Price-to-Projected Revenue Ratio|KRMD (KORU Medical) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple NYXH|MBOT: Forward Price to Sales|Forward P/S Multiple PDEX|Market Cap to Expected Sales Ratio zentek.com|Price-to-Projected Revenue Ratio Elutia ELUT|MLSS: Market Cap to Projected Revenue|Retractable Tech - Forward P/S Multiple|harvardbioscience.com (HBIO) - Forward Price-to-Revenue Multiple|FEMY (Femasys Inc.) - Forward Price-to-Revenue Multiple|MHUA - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Predictive Oncology Inc|Market Cap to Projected Revenue CJMB (Callan JMB Corp)|Forward Price-to-Revenue Multiple ATRI (Atrion Corp)|NeuroMetrix Corporation - Market Cap to Projected Revenue